AVT16

BIOLOGICAL2 trials

Sponsors

Alvotech Swiss AG

Conditions

HealthyUlcerative Colitis

Phase 1

Pilot Study of AVT16 in Healthy Adult Subjects

CompletedNCT06400719

Alvotech Swiss AGHealthy

Start: 2024-05-29End: 2024-11-06Updated: 2025-03-11

Phase 3

Study to Investigate Comparative Efficacy, Safety and Immunogenicity Between AVT16 and Entyvio

TerminatedNCT06570772

Alvotech Swiss AGUlcerative Colitis

Start: 2024-09-23End: 2025-11-25Updated: 2025-12-26